Loading…
Pharmahub (ფარმაჰაბი) — a short-lived Georgian pharmaceutical wholesaler/distributor (inferred from a thin ~8% gross margin in its main year and no consumer-facing presence). Reported revenue only for FY2020–2021 (~GEL 2–5.5m) and appears dormant thereafter.
| Ratio | 2020 | 2021 |
|---|---|---|
| Margins | ||
| Gross Margin | 34.5% | 7.8% |
| EBITDA Margin | 34.0% | 18.8% |
| EBITDAR | 719 | 1,031 |
| EBITDAR Margin | 34.0% | 18.8% |
| EBIT Margin | 34.0% | 18.8% |
| Net Profit Margin | 33.0% | 19.8% |
| Operating Expense % of Sales | 0.4% | 11.1% |
| Returns | ||
| Return on Assets (ROA) | 45.9% | 52.7% |
| Return on Equity (ROE) | 100.0% | 60.8% |
| ROIC [EBIT / Invested Capital] | 60.1% | 57.7% |
| Leverage & debt balances | ||
| Debt-to-Assets | 32.8% | 0.1% |
| Debt-to-Equity | 0.71x | 0.00x |
| Debt-to-EBITDA | 0.69x | 0.00x |
| Equity-to-Assets | 45.9% | 86.6% |
| Net Debt | 498 | 2 |
| Cash & Equivalents | 0 | 1 |
| Total Debt | 498 | 3 |
| Liquidity & working capital | ||
| Current Ratio | 1.85x | 7.46x |
| Quick Ratio | 1.71x | 7.36x |
| Cash Ratio | 0.00x | 0.00x |
| Total Current Assets | 1,520 | 2,051 |
| Total Current Liabilities | 822 | 275 |
| Inventory | 114 | 26 |
| Trade Receivables | 1,405 | 2,024 |
| Trade Payables | 324 | 273 |
| Net Working Capital | 698 | 1,776 |
| Net Working Capital % of Revenue | 33.0% | 32.5% |
| Trade Working Capital | 1,196 | 1,777 |
| Trade Working Capital % of Revenue | 56.6% | 32.5% |
| Change in Trade Working Capital | N/A | 581 |
| Turnover & efficiency | ||
| Inventory Turnover | 12.09x | 193.36x |
| Days Inventory Outstanding (DIO) | 30.2 | 1.9 |
| Receivables Turnover | 1.50x | 2.70x |
| Days Sales Outstanding (DSO) | 242.7 | 135.0 |
| Payables Turnover | 4.28x | 18.52x |
| Days Payable Outstanding (DPO) | 85.3 | 19.7 |
| Cash Conversion Cycle | 187.6 days | 117.2 days |
| Asset Turnover | 1.39x | 2.66x |
| Cash flow & dividends | ||
| Operating Cash Flow | -469 | -144 |
| Free Cash Flow (OCF − Capex proxy) | 41 | 4 |
| Cash Conversion (OCF / EBITDA) | -65.2% | -14.0% |
| Dividends Declared | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →